share_log

Manulife Financial Corporation to Issue S$500 Million 4.275% Subordinated Notes Due 2034

Manulife Financial Corporation to Issue S$500 Million 4.275% Subordinated Notes Due 2034

宏利金融公司將發行到期日期爲2034年的5億新加坡元4.275%次級票據
PR Newswire ·  06/11 23:44

TSX/NYSE/PSE: MFC SEHK: 945

tsx/紐交所/菲律賓證券交易所:宏利金融 香港聯交所:945

TORONTO, June 11, 2024 /PRNewswire/ - Manulife Financial Corporation ("Manulife") announced today that it has priced an offering in Singapore of S$500 million principal amount of 4.275% subordinated notes due June 19, 2034 (the "Notes"). The offering will be made pursuant to an offering circular dated June 11, 2024 and will qualify as Tier 2 capital for Manulife.

2024年6月11日多倫多/新華社-/宏利金融(Manulife)今天宣佈,該公司定價了在新加坡的500 million新元的4.275%次級票據,截至2034年6月19日到期(“票據”)。該發行將根據2024年6月11日的發售通告進行,並將爲宏利的第二層資本。

The Notes will bear interest at a fixed rate of 4.275% until June 19, 2029 and thereafter at a rate of 1.201% over the then-prevailing five-year SORA OIS rate. The Notes mature on June 19, 2034.

票據將以固定的4.275%利率計息,直到2029年6月19日爲止,此後按照當時的五年期SORA OIS利率加1.201%計息。票據將於2034年6月19日到期。

Manulife may, with the prior approval of the Superintendent of Financial Institutions (Canada), redeem the Notes in whole, but not in part, on June 19, 2029 and on any interest payment date thereafter at a redemption price equal to par, together with accrued and unpaid interest to, but excluding, the date fixed for redemption. The Notes will constitute subordinated indebtedness, ranking equally and rateably with all other subordinated indebtedness of Manulife from time to time issued and outstanding (other than subordinated indebtedness which has been further subordinated in accordance with its terms).

在加拿大金融機構監管局(Superintendent of Financial Institutions (Canada))的事先批准下,宏利可以在2029年6月19日和此後的任何利息支付日全額贖回,贖回價格爲票面值,加上贖回日期之前應計但未支付的利息,但不得部分贖回。票據將構成次級債務,與宏利從時間上已發行的和未償還的所有其他次級債務平等排位。

Approval in-principle has been received from the Singapore Exchange Securities Trading Limited (the "SGX-ST") for the listing and quotation of the Notes on the Official List of the SGX-ST. The SGX-ST takes no responsibility for the correctness of any of the statements made or opinions expressed or reports contained in this press release. Admission of the Notes to the Official List of the SGX-ST and quotation of the Notes on the SGX-ST are not to be taken as an indication of the merits of Manulife and its subsidiaries or the merits of the Notes.

新加坡證券交易所證券交易有限公司(SGX-ST)初步批准在SGX-ST官方名單上列出和報價票據。 SGX-ST對本新聞發佈中提出的任何聲明或表達的任何意見或報告的正確性不承擔責任。票據被列入SGX-ST的官方名單並在SGX-ST上報價,不代表宏利及其附屬公司或票據的優點。

DBS Bank Ltd. and Standard Chartered Bank (Singapore) Limited, have been appointed as joint lead managers and bookrunners for the offering. Australia and New Zealand Banking Group Limited and The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch have been appointed as co-managers for the offering.

DBS Bank Ltd和渣打銀行(新加坡)有限公司已被任命爲本次發行的聯席主承銷商和簿記管理人。澳新銀行有限公司(ANZ)和香港上海匯豐銀行有限公司新加坡分行已被任命爲本次發行的聯合經理人。

The offering is expected to close on June 19, 2024.

本次發行預計於2024年6月19日結束。

The Notes have not been and will not be registered in the United States under the United States Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state of the United States or other jurisdiction and may not be offered or sold within the United States, or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities law. The offering will be made solely to non-U.S. persons in offshore transactions pursuant to Regulation S under the Securities Act. This press release does not constitute an offer to sell or a solicitation to buy securities in the United States or any other jurisdiction where it is unlawful to do so.

票據未在美國1933年修正版的《證券法》(Securities Act)或美國任何州或其他司法管轄區的證券法下注冊,也不會註冊,不得在美國境內或向美國人(根據《證券法》規定,該定義爲《證券法》下Regulation S中的豁免條款或不受責任條款的交易中)直接或間接提供或出售,除非根據《證券法》和適用的州或地方法規的登記要求的豁免規定或不受管轄的交易中。本新聞發佈不構成在美國或任何其他禁止或限制這樣做的司法管轄區內出售或購買證券的要約。

The Notes will not be offered or sold, directly or indirectly, in Canada or to any resident of Canada.

票據不會直接或間接在加拿大或者向任何加拿大居民提供或出售。

About Manulife
關於宏利

Manulife Financial Corporation is a leading international financial services provider, helping people make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we provide financial advice and insurance, operating as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States. Through Manulife Investment Management, the global brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2023, we had more than 38,000 employees, over 98,000 agents, and thousands of distribution partners, serving over 35 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges, and under '945' in Hong Kong.

宏利金融公司是一家領先的國際金融服務提供商,致力於幫助人們更輕鬆地做決定並過上更好的生活。總部位於加拿大多倫多市,我們在加拿大、亞洲和歐洲經營金融諮詢和保險業務,並在美國主要以約翰·漢考克(John Hancock)的名義經營。通過宏利投資管理,我們的全球財富和資產管理業務品牌,我們服務於全球個人、機構和養老計劃成員。截至2023年末,我們擁有超過38,000名員工、超過98,000名代理商和數千名分銷合作伙伴,服務超過3500萬客戶。我們在多倫多、紐約和菲律賓證券交易所上交易爲'MFC',在香港上交所上交易爲'945'。

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.

並非所有產品在所有司法管轄區都可購買。有關更多信息,請訪問manulife.com。

SOURCE Manulife Financial Corporation

SOURCE宏利金融公司

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論